Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC33923101992;101993;101994 chr2:178534848;178534847;178534846chr2:179399575;179399574;179399573
N2AB3228297069;97070;97071 chr2:178534848;178534847;178534846chr2:179399575;179399574;179399573
N2A3135594288;94289;94290 chr2:178534848;178534847;178534846chr2:179399575;179399574;179399573
N2B2485874797;74798;74799 chr2:178534848;178534847;178534846chr2:179399575;179399574;179399573
Novex-12498375172;75173;75174 chr2:178534848;178534847;178534846chr2:179399575;179399574;179399573
Novex-22505075373;75374;75375 chr2:178534848;178534847;178534846chr2:179399575;179399574;179399573
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTC
  • RefSeq wild type template codon: CAG
  • Domain: Kinase-1
  • Domain position: 111
  • Q(SASA): 0.1396
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I None None None N None 0.159 0.351830644314 gnomAD-4.0.0 6.86481E-07 None None None None N None 0 0 None 0 0 None 0 0 8.9946E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.7133 likely_pathogenic 0.6208 pathogenic -2.322 Highly Destabilizing None None None None N 0.465218903 None None N
V/C 0.9446 likely_pathogenic 0.9296 pathogenic -2.012 Highly Destabilizing None None None None None None None None N
V/D 0.9881 likely_pathogenic 0.9847 pathogenic -3.63 Highly Destabilizing None None None None N 0.502240788 None None N
V/E 0.9643 likely_pathogenic 0.9574 pathogenic -3.324 Highly Destabilizing None None None None None None None None N
V/F 0.7625 likely_pathogenic 0.6718 pathogenic -1.519 Destabilizing None None None None N 0.475489253 None None N
V/G 0.8545 likely_pathogenic 0.8001 pathogenic -2.919 Highly Destabilizing None None None None N 0.501987298 None None N
V/H 0.9887 likely_pathogenic 0.9858 pathogenic -3.028 Highly Destabilizing None None None None None None None None N
V/I 0.1551 likely_benign 0.1313 benign -0.592 Destabilizing None None None None N 0.405912939 None None N
V/K 0.981 likely_pathogenic 0.9768 pathogenic -2.232 Highly Destabilizing None None None None None None None None N
V/L 0.6709 likely_pathogenic 0.5703 pathogenic -0.592 Destabilizing None None None None N 0.440046943 None None N
V/M 0.6484 likely_pathogenic 0.5417 ambiguous -0.739 Destabilizing None None None None None None None None N
V/N 0.9584 likely_pathogenic 0.9474 pathogenic -2.921 Highly Destabilizing None None None None None None None None N
V/P 0.9971 likely_pathogenic 0.9959 pathogenic -1.15 Destabilizing None None None None None None None None N
V/Q 0.9652 likely_pathogenic 0.9598 pathogenic -2.578 Highly Destabilizing None None None None None None None None N
V/R 0.9677 likely_pathogenic 0.9632 pathogenic -2.271 Highly Destabilizing None None None None None None None None N
V/S 0.8594 likely_pathogenic 0.8239 pathogenic -3.395 Highly Destabilizing None None None None None None None None N
V/T 0.691 likely_pathogenic 0.6289 pathogenic -2.929 Highly Destabilizing None None None None None None None None N
V/W 0.9955 likely_pathogenic 0.9929 pathogenic -2.22 Highly Destabilizing None None None None None None None None N
V/Y 0.9621 likely_pathogenic 0.9509 pathogenic -1.828 Destabilizing None None None None None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.